Published in Fortschr Neurol Psychiatr on February 01, 1998
Brain modules of hallucination: an analysis of multiple patients with brain lesions. J Psychiatry Neurosci (2003) 0.80
Computer-based training for the treatment of partial blindness. Nat Med (1998) 2.80
Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann Neurol (1989) 2.01
Does visual restitution training change absolute homonymous visual field defects? A fundus controlled study. Br J Ophthalmol (2005) 1.54
Caldendrin, a novel neuronal calcium-binding protein confined to the somato-dendritic compartment. J Biol Chem (1998) 1.31
Nanoparticle technology for delivery of drugs across the blood-brain barrier. J Pharm Sci (1998) 1.27
Stability of visual field enlargements following computer-based restitution training -- results of a follow-up. J Clin Exp Neuropsychol (2001) 1.19
Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine. Invest Ophthalmol Vis Sci (1996) 1.15
Restoration of vision II: residual functions and training-induced visual field enlargement in brain-damaged patients. Restor Neurol Neurosci (1999) 1.11
Residual vision in transition zones in patients with cerebral blindness. J Clin Exp Neuropsychol (1998) 1.10
Assessing spatial vision - automated measurement of the contrast-sensitivity function in the hooded rat. J Neurosci Methods (2000) 1.10
Visual field enlargement after computer training in brain-damaged patients with homonymous deficits: an open pilot trial. Restor Neurol Neurosci (1995) 1.08
Apoptotic versus necrotic characteristics of retinal ganglion cell death after partial optic nerve injury. J Neurotrauma (1999) 1.06
Vision restoration therapy. Br J Ophthalmol (2005) 1.04
Unusual spontaneous and training induced visual field recovery in a patient with a gunshot lesion. J Neurol Neurosurg Psychiatry (2001) 0.97
Acute effects of alcohol on divided and covert attention in men. Psychopharmacology (Berl) (2001) 0.97
GM1 ganglioside treatment reduces visual deficits after graded crush of the rat optic nerve. Brain Res (1991) 0.94
Computer-based training of stimulus detection improves color and simple pattern recognition in the defective field of hemianopic subjects. J Cogn Neurosci (2000) 0.90
Toward a unified theory of ganglioside-mediated functional restoration after brain injury: lesion size, not lesion site, is the primary factor determining efficacy. Acta Neurobiol Exp (Wars) (1990) 0.90
Automobile driving performance of brain-injured patients with visual field defects. Am J Phys Med Rehabil (1999) 0.90
[The neuroophthalmic supplement to the NEI-VFQ: test statistics and validation with a cohort of patients with pre- and postchiasmatic damage]. Klin Monbl Augenheilkd (2011) 0.88
Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections. Brain Res (1996) 0.88
Altered white matter integrity in adolescents with prelingual deafness: a high-resolution tract-based spatial statistics imaging study. AJNR Am J Neuroradiol (2012) 0.87
Programs for diagnosis and therapy of visual field deficits in vision rehabilitation. Spat Vis (1997) 0.86
Recovery of brightness discrimination in adult rats despite progressive loss of retrogradely labelled retinal ganglion cells after controlled optic nerve crush. Eur J Neurosci (1993) 0.85
Visual hallucinations during spontaneous and training-induced visual field recovery. Neuropsychologia (2007) 0.84
Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier. Peptides (1998) 0.84
Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome. Restor Neurol Neurosci (1990) 0.83
Two faces of calcium activation after optic nerve trauma: life or death of retinal ganglion cells in vivo depends on calcium dynamics. Eur J Neurosci (2007) 0.83
Quinolinic acid released from polymeric brain implants causes behavioral and neuroanatomical alterations in a rodent model of Huntington's disease. Exp Neurol (2000) 0.83
Anatomical correlations of intrinsic axon repair after partial optic nerve crush in rats. Ann Anat (2002) 0.83
Controlled release of dopamine from a polymeric brain implant: in vitro characterization. Exp Neurol (1989) 0.82
Expression and subcellular localization of p42IP4/centaurin-alpha, a brain-specific, high-affinity receptor for inositol 1,3,4,5-tetrakisphosphate and phosphatidylinositol 3,4,5-trisphosphate in rat brain. Eur J Neurosci (1997) 0.82
[Impairments of vision- and health-related quality of life in stroke patients with homonymous visual field defects depend on severity of visual function loss]. Klin Monbl Augenheilkd (2009) 0.81
In vivo imaging of mammalian central nervous system neurons with the in vivo confocal neuroimaging (ICON) method. Methods Enzymol (1999) 0.81
Structural abnormalities in early Tourette syndrome children: a combined voxel-based morphometry and tract-based spatial statistics study. PLoS One (2013) 0.81
Quantification of the human lateral geniculate nucleus in vivo using MR imaging based on morphometry: volume loss with age. AJNR Am J Neuroradiol (2012) 0.80
[Visual field defects after cerebral lesions from the patient's perspective: health- and vision-related quality of life assessed by SF-36 and NEI-VFQ]. Nervenarzt (2008) 0.80
Amphetamine induces hypermotility in MPTP-lesioned mice. Pharmacol Biochem Behav (1997) 0.79
Restoration of vision IV: role of compensatory soma swelling of surviving retinal ganglion cells in recovery of vision after optic nerve crush. Restor Neurol Neurosci (2001) 0.79
A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers. Neurosci Lett (1994) 0.79
GM1 ganglioside treatment facilitates behavioral recovery from bilateral brain damage. Science (1984) 0.79
Susceptibility of retinal ganglion cells to excitotoxicity depends on soma size and retinal eccentricity. Curr Eye Res (1999) 0.79
Extensive loss of subcortical neurons in the aging rat brain. Exp Neurol (1981) 0.78
Biochemical and behavioral recovery in a rodent model of Parkinson's disease following stereotactic implantation of dopamine-containing liposomes. Exp Neurol (1992) 0.78
Behavioral effects of intracerebral injections of renin and captopril in intact and brain-damaged rats. Brain Res Bull (1983) 0.78
MK-801 reduces retinal ganglion cell survival but improves visual performance after controlled optic nerve crush. J Neurotrauma (1996) 0.78
Restoration of vision after optic nerve lesions with noninvasive transorbital alternating current stimulation: a clinical observational study. Brain Stimul (2011) 0.78
Protease-activated receptor subtype expression in developing eye and adult retina of the rat after optic nerve crush. J Neurosci Res (2003) 0.78
Influence of nanoparticles on the brain-to-serum distribution and the metabolism of valproic acid in mice. J Pharm Pharmacol (2000) 0.78
Intracerebral injections of isotonic saline prevent behavioral deficits from brain damage. Physiol Behav (1982) 0.78
Co-expression of c-Jun and ATF-2 characterizes the surviving retinal ganglion cells which maintain axonal connections after partial optic nerve injury. Brain Res Mol Brain Res (1999) 0.78
L-type calcium channel antagonist nifedipine reduces neurofilament restitution following traumatic optic nerve injury. Acta Neurochir Suppl (2004) 0.78
Body distribution of 3H-labelled dalargin bound to poly(butyl cyanoacrylate) nanoparticles after i.v. injections to mice. Life Sci (2000) 0.78
[Do patients undergo changes of their personality due to visual field defects? An investigation with FPI-R and NEI-VQ]. Klin Monbl Augenheilkd (2008) 0.78
Pharmacological treatment of central nervous system injury. Nature (1986) 0.77
Charles Bonnet syndrome (visual hallucinations) following enucleation. Eye (Lond) (2006) 0.77
Restoration of vision III: soma swelling dynamics predicts neuronal death or survival after optic nerve crush in vivo. Neuroreport (1999) 0.77
Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory. Br J Pharmacol (2000) 0.77
Changes in rapidly transported proteins associated with development of abnormal projections in the diencephalon. Brain Res (1992) 0.77
Editorial: Residual vision and plasticity after visual system damage. Restor Neurol Neurosci (1999) 0.77
Reduction of anterograde degeneration in brain damaged rats by GM1-gangliosides. Neurosci Lett (1987) 0.76
Long-term stability of PBCA nanoparticle suspensions. J Microencapsul (2000) 0.76
Simulation of psychosis by continuous delivery of phencyclidine from controlled-release polymer implants. Behav Brain Res (1998) 0.76
Small drug sample fabrication of controlled release polymers using the microextrusion method. J Neurosci Methods (1998) 0.76
Axonal injury alters alternative splicing of the retinal NR1 receptor: the preferential expression of the NR1b isoforms is crucial for retinal ganglion cell survival. J Neurosci (1998) 0.76
Systemic L-kynurenine administration partially protects against NMDA, but not kainate-induced degeneration of retinal ganglion cells, and reduces visual discrimination deficits in adults rats. Invest Ophthalmol Vis Sci (1996) 0.75
Haloperidol-induced behavioral supersensitivity is increased by monosialoganglioside treatment in rats without affecting spiroperidol-binding. J Pharmacol Exp Ther (1994) 0.75
Gangliosides minimize behavioral deficits and enhance structural repair after brain injury. J Neurosci Res (1984) 0.75
Subchronically applied phencyclidine fails to disrupt prepulse inhibition in rats. Eur Neuropsychopharmacol (1999) 0.75
Isolation of functionally intact pig retina mitochondria. Acta Ophthalmol Scand (1996) 0.75
[Transcendental meditation in psychology, psychiatry and psychotherapy]. Med Klin (1979) 0.75
Special issues in brain plasticity, repair and rehabilitation: 20 years of a publishing strategy. Restor Neurol Neurosci (2010) 0.75
Diffusion enhancement of drugs by loaded nanoparticles in vitro. Prog Neuropsychopharmacol Biol Psychiatry (1999) 0.75
Loss and subsequent recovery of local cerebral glucose use in visual targets after controlled optic nerve crush in adult rats. Exp Neurol (1996) 0.75
GM1 gangliosides stimulate neuronal reorganization and reduce rotational asymmetry after hemitransections of the nigro-striatal pathway. Exp Brain Res (1985) 0.75
R-esp1, a rat homologue of drosophila groucho, is differentially expressed after optic nerve crush and mediates NGF-induced survival of PC12 cells. FEBS Lett (1999) 0.75
Evidence for gene transcription of adenohypophyseal hormones in the ovine pars tuberalis. Neuroendocrinology (1996) 0.75
Basic fibroblast growth factor treatment partially protects from visual deficits but does not increase retinal ganglion cell survival following controlled optic nerve crush. Restor Neurol Neurosci (1996) 0.75
Molecular plasticity of retinal ganglion cells after partial optic nerve injury. Restor Neurol Neurosci (1999) 0.75
Deficits of respiratory-cardiac coupling in heavy drinkers. Prog Neuropsychopharmacol Biol Psychiatry (2001) 0.75
Recovery of metabolic activity in retinofugal targets after traumatic optic nerve injury is independent of retinofugal input. Restor Neurol Neurosci (1998) 0.75
[Possibilities for mobility of blind patients]. Klin Monbl Augenheilkd (1999) 0.75
The saline effect: minimizing the severity of brain damage by reduction of secondary degeneration. Exp Neurol (1985) 0.75
Interhemispheric nigrothalamic projections and behavioral recovery following turning behavior induced by unilateral peripheral sensory and motor restriction. Exp Neurol (1984) 0.75
The role of striatal glutamatergic system in haloperidol-induced dopamine receptor supersensitivity and effects of monosialoganglioside GM1. Pharmacol Biochem Behav (1997) 0.75
Publishing in the field of brain plasticity, repair and rehabilitation: The 20th Anniversary issue of Restorative Neurology and Neuroscience. Restor Neurol Neurosci (2009) 0.75
Science reunification in Germany: a crash program. Science (1993) 0.75
Localization of a 42-kDa inositol 1,3,4,5-tetrakisphosphate receptor protein in retina and change in expression after optic nerve injury. Brain Res Mol Brain Res (1997) 0.75